Multiple endocrine neoplasia [MEN] syndromes digital illustration

Multiple endocrine neoplasia [MEN] syndromes Save

ICD-10 code: E31.2

Chapter: Endocrine, nutritional and metabolic diseases

Understanding Multiple Endocrine Neoplasia [MEN] Syndromes

Multiple Endocrine Neoplasia (MEN) syndromes are rare genetic conditions that affect the endocrine system. The endocrine system is responsible for producing hormones that regulate various bodily functions. MEN syndromes cause tumors to develop in multiple endocrine glands, which can lead to the overproduction of hormones and other health problems.

There are three types of MEN syndromes:

  1. MEN1
  2. MEN2A
  3. MEN2B

MEN1 is the most common type of MEN syndrome, affecting approximately 1 in 30,000 people. It is caused by a mutation in the MEN1 gene, which normally suppresses tumor growth. MEN1 syndrome can cause tumors in the parathyroid glands, pancreas, and pituitary gland.

MEN2A and MEN2B are caused by mutations in the RET gene. MEN2A affects approximately 1 in 35,000 people, while MEN2B is much rarer, affecting only 1 in 1 million people. Both types of MEN2 syndrome can cause tumors in the thyroid gland, adrenal gland, and parathyroid gland.

Symptoms of MEN syndromes can vary depending on the type and location of the tumors. Some common symptoms include:

  • Abdominal pain
  • Bone pain
  • Fatigue
  • High blood pressure
  • Increased thirst and urination
  • Muscle weakness
  • Nausea and vomiting

MEN syndromes are usually diagnosed through a combination of genetic testing, blood tests, and imaging studies. Treatment options may include surgery to remove tumors, medications to reduce hormone production, and regular monitoring to detect any new tumors that may develop.

If you or a loved one has been diagnosed with a MEN syndrome, it is important to work closely with your healthcare team to manage your condition and prevent complications. With proper treatment and monitoring, many people with MEN syndromes are able to live healthy, productive lives.